# Shingrix in Renal Transplant Recipients

Study · id `cardio:ct-nct04128189` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04128189](<https://clinicaltrials.gov/study/NCT04128189>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04128189

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 132 participants.

## Technical summary

Registry record NCT04128189. Randomized; no masking; primary purpose treatment. Start 2023-03-02 (actual); primary completion 2029-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 132 participants (planned count; ClinicalTrials.gov record NCT04128189, source copy `cardio:ctgov-nct04128189-2026-04-08`, retrieved 2026-10-26)
- Started: 2023-03-02 (actual) (ClinicalTrials.gov record NCT04128189, source copy `cardio:ctgov-nct04128189-2026-04-08`, retrieved 2026-10-26)
- Primary completion: 2029-06 (anticipated) (ClinicalTrials.gov record NCT04128189, source copy `cardio:ctgov-nct04128189-2026-04-08`, retrieved 2026-10-26)
- Completion: 2029-06 (anticipated) (ClinicalTrials.gov record NCT04128189, source copy `cardio:ctgov-nct04128189-2026-04-08`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04128189, source copy `cardio:ctgov-nct04128189-2026-04-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04128189-2026-04-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Shingrix in Renal Transplant Recipients
- Condition: Kidney Transplant Recipient Response to Shingrix Vaccine
- Condition: Kidney Failure
- Condition: Kidney Failure, Chronic
- Condition: Kidney Transplantation
- Condition: Herpes Zoster (HZ)
- Intervention (Biological): Shingrix
- Lead sponsor: University of Colorado, Denver
- Lead sponsor class: OTHER
- Collaborator: GlaxoSmithKline
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: University of Colorado, Denver (`cardio:org-university-of-colorado-denver`)
- Registry lists this organization as a collaborator: GlaxoSmithKline (`cardio:org-glaxosmithkline`)

## Provenance

Content hash: d03865604ad7552890eeedf4980471dfd868499ca45acb9f76912d3094756b12
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
